Patent ductus arteriosus pathophysiology

Patent Ductus Arteriosus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Causes
Differentiating Patent Ductus Arteriosus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Other Imaging Findings
Treatment
Medical Therapy
Preterm Infants
Term and Older Children
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Patent ductus arteriosus pathophysiology On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Patent ductus arteriosus pathophysiology All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Patent ductus arteriosus pathophysiology
CDC on Patent ductus arteriosus pathophysiology
Patent ductus arteriosus pathophysiology in the news
Blogs on Patent ductus arteriosus pathophysiology
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Patent ductus arteriosus pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Priyamvada Singh, M.B.B.S. [2], Cafer Zorkun, M.D., Ph.D. [3], Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Overview

The pathophysiological findings depend on the size of defect and the pulmonary vascular resistance

Pathophysiology

The pathophysiological consequences depend on the size of the defect and the pulmonary vascular resistance.

Small PDA

1. Small left-to-right shunt (Qp/Qs < 1.5).
2. Normal ratio of pulmonary artery (PA) to systemic pressure.
3. Shunt throughout the cardiac cycle, continuous murmur.

Medium-sized PDA

1. Qp/Qs 1.5 to 2.0 yet small enough to offer some resistance to flow.
2. PA systolic to systemic pressures are < 0.5.
3. Unusual for this group to have markedly increased PVR.
4. Due to increased return to the left heart, there is volume overload of the left atrium (LA) and the left ventricle (LV).

Large PDA

1. Defect does not restrict flow.
2. There is pulmonary hypertension at near systemic pressures (PA systolic/systolic pressure is >0.5).
3. Because of the physiologic decrease in the PVR over the first three months of life there is a large left-to-right shunt with Qp/Qs > 2.
4. The large volume overload of the left ventricle may result in LV failure.
5. There is pulmonary hypertension.
6. There may be two courses:
   1. A decrease in the relative size of the ductus compared with other cardiovascular structures. This results in a medium-sized defect compared with the course expected for a medium-sized defect.
   2. The development of severe pulmonary vascular obstructive disease, can occur at any time from age 3 until early adulthood. The left-to-right shunt converts to a right-to-left shunt with cyanosis and disappearance of the continuous murmur.

External links

• High-Risk Newborn - Patent Ductus Arteriosus (PDA)
• Patent Ductus Arteriosus from Merck
• Fetal Circulation at berkeley.edu
• Goldminer: Patent ductus arteriosus